Agency Information Collection Activities; Proposed Collection; Comments Requested: Annual Reporting Requirement for Manufacturers of Listed Chemicals, 6349-6350 [2013-01874]

Download as PDF Federal Register / Vol. 78, No. 20 / Wednesday, January 30, 2013 / Notices Overview of Information Collection 1117–0031 (1) Type of Information Collection: Extension of a currently approved collection (2) Title of the Form/Collection: Application for Registration under Domestic Chemical Diversion Control Act of 1993 and Renewal Application for Registration under Domestic Chemical Diversion Control Act of 1993. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA Forms 510 and 510a. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: The Domestic Chemical Diversion Control Act requires that manufacturers, distributors, importers, and exporters of List I chemicals which Respondents 6349 may be diverted in the United States for the production of illicit drugs must register with DEA. Registration provides a system of controls to aid in the tracking of the distribution of List I chemicals. (4) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: Burden (minutes) Total hour burden @ $50.14/hour = DEA–510 (paper) .................................................................................... DEA–510 (electronic) .............................................................................. DEA–510a (paper) .................................................................................. DEA–510a (electronic) ............................................................................ 17 143 158 896 0.5 hours .......... 0.25 hours ........ 0.5 hours .......... 0.25 hours ........ 8.5 35.75 79 224 $448.80 1,887.60 4,171.20 11,827.20 Total ................................................................................................. 1,054 ........................... 347.25 18,334.80 Total percentage electronic: 98.5% (5) An estimate of the total public burden (in hours) associated with the collection: DEA estimates that this collection takes 347.25 annual burden hours. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. Dated: January 24, 2013. Jerri Murray, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. 2013–01868 Filed 1–29–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0029] Agency Information Collection Activities; Proposed Collection; Comments Requested: Annual Reporting Requirement for Manufacturers of Listed Chemicals mstockstill on DSK4VPTVN1PROD with ACTION: 30-Day notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is VerDate Mar<15>2010 20:43 Jan 29, 2013 Jkt 229001 published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 227, pages 70472–70473 on November 26, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until March 1, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/ or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Annual Reporting Requirement for Manufacturers of Listed Chemicals. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: None. Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: This information collection permits the Drug Enforcement Administration to monitor the volume and availability of domestically manufactured listed chemicals. These listed chemicals may be subject to diversion for the illicit production of controlled substances. This information collection is required by law. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that there are one hundred (100) total respondents for E:\FR\FM\30JAN1.SGM 30JAN1 6350 Federal Register / Vol. 78, No. 20 / Wednesday, January 30, 2013 / Notices this information collection. One hundred (100) persons respond at 1 hour per response. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that there are 100 annual burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. Dated: January 24, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–01874 Filed 1–29–13; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; PCAS-Nanosyn, LLC Schedule mstockstill on DSK4VPTVN1PROD with II II II II II II II II II II II II The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of controlled substances in bulk form only. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in VerDate Mar<15>2010 20:43 Jan 29, 2013 Jkt 229001 [FR Doc. 2013–01864 Filed 1–29–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Occupational Safety and Health Administration [Docket No. OSHA–2012–0040] Occupational Safety and Health Administration (OSHA), Labor. ACTION: Request for public comments. AGENCY: Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 4, 2012, PCAS-Nanosyn, LLC, 3331–B Industrial Drive, Santa Rosa, California 95403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Phencyclidine (7471) .................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Morphine (9300) ........................... Oxymorphone (9652) ................... Fentanyl (9801) ............................ Dated: January 15, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. The Standard on 4,4′Methylenedianiline for General Industry; Extension of the Office of Management and Budget’s (OMB) Approval of Information Collection (Paperwork) Requirements DEPARTMENT OF JUSTICE Drug quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 1, 2013. OSHA solicits public comments concerning its proposal to extend the Office of Management and Budget’s (OMB) approval of the information collection requirements specified in the Standard on 4,4′Methylenedianiline for General Industry (29 CFR 1910.1050). DATES: Comments must be submitted (postmarked, sent, or received) by April 1, 2013. ADDRESSES: Electronically: You may submit comments and attachments electronically at https:// www.regulations.gov, which is the Federal eRulemaking Portal. Follow the instructions online for submitting comments. Facsimile: If your comments, including attachments, are not longer than 10 pages, you may fax them to the OSHA Docket Office at (202) 693–1648. Mail, hand delivery, express mail, messenger, or courier service: When using this method, you must submit a copy of your comments and attachments to the OSHA Docket Office, Docket No. OSHA–2012–0040, Occupational Safety and Health Administration, U.S. Department of Labor, Room N–2625, 200 Constitution Avenue NW., Washington, DC 20210. Deliveries (hand, express mail, messenger, and courier service) are accepted during the Department of Labor’s and Docket SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Office’s normal business hours, 8:15 a.m. to 4:45 p.m., e.t. Instructions: All submissions must include the Agency name and OSHA docket number (OSHA–2012–0040) for the Information Collection Request (ICR). All comments, including any personal information you provide, are placed in the public docket without change, and may be made available online at https://www.regulations.gov. For further information on submitting comments see the ‘‘Public Participation’’ heading in the section of this notice titled SUPPLEMENTARY INFORMATION. Docket: To read or download comments or other material in the docket, go to https://www.regulations.gov or the OSHA Docket Office at the address above. All documents in the docket (including this Federal Register notice) are listed in the https:// www.regulations.gov index; however, some information (e.g., copyrighted material) is not publicly available to read or download from the Web site. All submissions, including copyrighted material, are available for inspection and copying at the OSHA Docket Office. You may also contact Theda Kenney at the address below to obtain a copy of the ICR. FOR FURTHER INFORMATION CONTACT: Theda Kenney or Todd Owen, Directorate of Standards and Guidance, OSHA, U.S. Department of Labor, Room N–3609, 200 Constitution Avenue NW., Washington, DC 20210; telephone (202) 693–2222. SUPPLEMENTARY INFORMATION: I. Background The Department of Labor, as part of its continuing effort to reduce paperwork and respondent (i.e., employer) burden, conducts a preclearance consultation program to provide the public with an opportunity to comment on proposed and continuing information collection requirements in accord with the Paperwork Reduction Act of 1995 (44 U.S.C. 3506(c)(2)(A)). This program ensures that information is in the desired format, reporting burden (time and costs) is minimal, collection instruments are clearly understood, and OSHA’s estimate of the information collection burden is accurate. The Occupational Safety and Health Act of 1970 (the OSH Act) (29 U.S.C. 651 et seq.) authorizes information collection by employers as necessary or appropriate for enforcement of the OSH Act or for developing information regarding the causes and prevention of occupational injuries, illnesses, and accidents (29 U.S.C. 657). The OSH Act E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 78, Number 20 (Wednesday, January 30, 2013)]
[Notices]
[Pages 6349-6350]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01874]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0029]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested: Annual Reporting Requirement for Manufacturers of 
Listed Chemicals

ACTION: 30-Day notice.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 77, Number 227, 
pages 70472-70473 on November 26, 2012, allowing for a 60 day comment 
period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until March 1, 2013. This process is conducted in 
accordance with 5 CFR 1320.10. Written comments and/or suggestions 
regarding the items contained in this notice, especially the estimated 
public burden and associated response time, should be directed to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503. Additionally, comments may be submitted to OMB via facsimile to 
(202) 395-7285. Written comments and suggestions from the public and 
affected agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Annual Reporting Requirement for 
Manufacturers of Listed Chemicals.
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection: Form number: None. Office of 
Diversion Control, Drug Enforcement Administration, U.S. Department of 
Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: This information collection permits the Drug Enforcement 
Administration to monitor the volume and availability of domestically 
manufactured listed chemicals. These listed chemicals may be subject to 
diversion for the illicit production of controlled substances. This 
information collection is required by law.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: It is estimated 
that there are one hundred (100) total respondents for

[[Page 6350]]

this information collection. One hundred (100) persons respond at 1 
hour per response.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: It is estimated that there are 100 annual burden 
hours associated with this collection.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Room 3W-1407B, Washington, DC 
20530.

    Dated: January 24, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2013-01874 Filed 1-29-13; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.